New research from the University of Virginia School of Medicine quantifies the antibody response generated by the Pfizer and Moderna…
Home »
Naive B cells could be useful for predicting vaccination response in immunocompromised
A recent study conducted at the Medical University of Graz, Austria, has revealed that the number of naïve B cells…
Monoclonal antibody prevents malaria in small NIH trial
One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for…
Vaccine antibody levels start to wane at around 2–3 months
Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by…
Can prior human seasonal coronavirus antibody response patterns predict SARS-CoV-2 inhibition?
To date, the ongoing novel coronavirus disease 2019 (COVID-19) – caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…
Early B cell signatures predict antibody responses to mRNA-based COVID-19 vaccine
Researchers in the United States have identified both antigen-specific and antigen non-specific predictive signatures of antibody responses to Moderna’s two-dose…
NIH to conduct large trial for COVID-19 polyclonal antibody therapies
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new…
Study examines antibody response to COVID-19 vaccination in patients with kidney failure
In a recent study, most patients with kidney failure who were undergoing hemodialysis developed a substantial antibody response following the…
New approach to cancer immunotherapy may prevent autoimmunity
A team of researchers has found disrupting the interaction between cancer cells and certain immune cells is more effective at…
Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers
Researchers at the New York State Department of Health in the United States have said concerning mutations within the B.1.526…